Skip Navigation LinksHome > January/February 2012 - Volume 36 - Issue 1 > Dynamic Contrast-Enhanced Magnetic Resonance Imaging–Derived...
Journal of Computer Assisted Tomography:
doi: 10.1097/RCT.0b013e31823f6c59

Dynamic Contrast-Enhanced Magnetic Resonance Imaging–Derived kep as a Potential Biomarker of Matrix Metalloproteinase 9 Expression in Patients With Glioblastoma Multiforme: A Pilot Study

Awasthi, Rishi MSc; Pandey, Chandra M. PhD; Sahoo, Prativa MSc; Behari, Sanjay MCh; Kumar, Vijendra MS; Kumar, Shaleen MD; Misra, Shagun MD; Husain, Nuzhat MD; Soni, Priyanka MSc; Rathore, Ram K.S. PhD; Gupta, Rakesh Kumar MD

Collapse Box


Objective: To look for the association of tissue matrix metalloproteinase 9 (MMP-9) expression with dynamic contrast-enhanced magnetic resonance imaging and to see whether these can prognosticate patients with glioblastoma multiforme (GBM).

Methods: Forty-seven patients with GBM underwent dynamic contrast-enhanced magnetic resonance imaging to look for association of its indices with tissue MMP-9 expression using Pearson correlation. Kaplan-Meier survival analysis was performed to study the survival pattern for low-, medium-, and high-tissue MMP-9 expression and kep values.

Results: Among perfusion indices, kep, ktrans, and ve significantly correlated with MMP-9 expression. Matrix metalloproteinase 9 expression was found to be best estimated by kep using a quadratic model. The 1-year survival in low-, medium-, and high-tissue MMP-9 and kep groups were 59%, 45%, and 7%, and 59%, 33%, and 15%, respectively.

Conclusion: The association of kep and MMP-9 expression with survival suggests that kep may be used as imaging biomarker of GBM progression and its prognostication.

Copyright © 2012 Wolters Kluwer Health, Inc. All rights reserved.



Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.